Primary literature |
Mullally MM, Meisel H, FitzGerald RJ. Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol Chem Hoppe Seyler. 1996 Apr;377(4):259-60.
|
Other literature(s) |
[1] Fitzgerald R J, Meisel H. Lactokinins: Whey protein‐derived ACE inhibitory peptides[J]. Molecular Nutrition (&) Food Research, 1999, 43(3):165. [2] Cushman D. W., 1981. Angiotensin converting enzyme inhibitors: Evolution
of a new class of antihypertensive drugs (page 19). in: Horovitz Z. P.
(Ed.)(1981), Mechanisms of action and clinical implications, Urban &
Schwarzenberg. [4] Mullally M M, Meisel H, Fitzgerald R J. Synthetic peptides corresponding
to alpha-lactalbumin and beta-lactoglobulin sequences with
angiotensin-I-converting enzyme inhibitory activity.[J]. Biol Chem Hoppe
Seyler, 1996, 377(4):259-260. [5] Ap D L R, Montoya A B, Martã-Nez-Cuevas P, et al. Tryptic amaranth glutelin digests induce endothelial nitric oxide production through inhibition of ACE: antihypertensive role of amaranth peptides[J]. Nitric Oxide, 2010, 23(2):106-111.
|
PubDate |
1996 |